Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
RESEARCH TOOLSreports
RBOT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.27 - $19.00
Previous CloseN/A
Volume30.88K
Average Volume (3M)48.51K
Market Cap
$92.76M
Enterprise Value-$13.29M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.95
Next Earnings
Feb 27, 2025EPS Estimate
-2.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.66
Shares Outstanding5,254,229
10 Day Avg. Volume61,597
30 Day Avg. Volume48,511
Standard Deviation0.23
R-Squared0.07
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.17
Enterprise Value/Ebitda0.22
Forecast
1Y Price Target
$10.00Price Target Upside-31.60% Downside
Rating ConsensusHold
Number of Analyst Covering1
---
Vicarious Surgical News
PremiumCompany Announcements
Vicarious Surgical Announces COO Retirement in 2025
PremiumCompany Announcements
Vicarious Surgical Secures Advisory Role with Former CFO
PremiumCompany Announcements
Vicarious Surgical Announces CFO William Kelly’s Resignation
---
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe 3Q call shed more light on RBOT's clinical trial design and testing locations, indicating progress in evaluating potential trial sites and moving towards pivotal trials.
Product DevelopmentFinal integration of the Version 1.0 System is just weeks away, which should allow the company to move towards V&V testing and its first clinical patient experience next year.
Bears Say
Financial NeedsRBOT exited 3Q24 with $60.9M in cash and will likely need additional capital to bring its system to market.
Leadership ChangesThe CFO departure is seen as another challenge for RBOT to handle on its path towards gaining clearance.
Market TimingThe pathway to approval for RBOT has been challenging with timelines projected out to late FY26 and into FY27 before commercial launch.
---
Ownership Overview
48.83% Insiders
3.74% Mutual Funds
28.97% Other Institutional Investors
15.56% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RBOT FAQ
What was Vicarious Surgical’s price range in the past 12 months?
Vicarious Surgical lowest stock price was $4.27 and its highest was $19.00 in the past 12 months.
What is Vicarious Surgical’s market cap?
Vicarious Surgical’s market cap is $92.76M.
When is Vicarious Surgical’s upcoming earnings report date?
Vicarious Surgical’s upcoming earnings report date is Feb 27, 2025 which is in 5 days.
How were Vicarious Surgical’s earnings last quarter?
Vicarious Surgical released its earnings results on Nov 12, 2024. The company reported -$2.877 earnings per share for the quarter, missing the consensus estimate of -$2.575 by -$0.302.
Is Vicarious Surgical overvalued?
According to Wall Street analysts Vicarious Surgical’s price is currently Overvalued.
Does Vicarious Surgical pay dividends?
Vicarious Surgical does not currently pay dividends.
What is Vicarious Surgical’s EPS estimate?
Vicarious Surgical’s EPS estimate is -2.69.
How many shares outstanding does Vicarious Surgical have?
Vicarious Surgical has 5,254,229 shares outstanding.
What happened to Vicarious Surgical’s price movement after its last earnings report?
Vicarious Surgical reported an EPS of -$2.877 in its last earnings report, missing expectations of -$2.575. Following the earnings report the stock price went down -17.864%.
Which hedge fund is a major shareholder of Vicarious Surgical?
Currently, no hedge funds are holding shares in RBOT
---
Vicarious Surgical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.00 (-31.60% Downside)
$10.00 (-31.60% Downside)
Insider Transactions
Sold Shares
Worth $57.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.8%
Last 30 Days ▲ 11.0%
Last 30 Days ▲ 11.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.23%
12-Months-Change
Fundamentals
Return on Equity
-75.30%
Trailing 12-Months
Asset Growth
-38.95%
Trailing 12-Months
Company Description
Vicarious Surgical
D8 Holdings Corp is a blank check company.
---
RBOT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call was largely focused on the positive strides made in reducing operational costs, advancing the single-port platform, and maintaining a strong financial position. However, significant challenges remain, including the need to achieve regulatory approval and address ongoing net losses.Read More>---
RBOT Stock 12 Month Forecast
Average Price Target
$10.00
▼(-31.60% Downside)
Technical Analysis
Best Analysts Covering RBOT
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+37.57%
assigned a buy rating 3 months ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +37.57% per trade.
---